This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit April 09, 2014

Home  About Us  Advocacy   CSHP 2015   Events   Membership   Products & Publications   Programs Resources   Contact Us



 




Disclaimer: CSHP e-Newsbrief is a weekly listing featuring the latest news of interest to hospital pharmacists, selected from thousands of sources by the editors of MultiView. CSHP personnel approve the final summaries; any comments regarding content of this publication should be emailed to CSHP. It should not be understood or implied from the presence of advertisements that CSHP endorses any products or services advertised. MultiView and CSHP are not liable for any delays or inaccuracies in the information contained in this brief, nor for any actions taken or outcomes resulting from relying on the information provided herein.



In this issue:

Canada Health Accord expires, prompting protest, uncertainty
Drug reviews mostly stay secret
Think twice about tests, doctors urged
Canadian researchers developing treatment for celiac disease
Study finds 1 in 3 prescriptions unfilled, some for chronic conditions
Government announces new steps to help medical community with marijuana for medical purposes
Relationships of services, associations with antibiotic-resistant organisms in Canadian acute care hospitals
Toronto hospital courts wealthy 'medical tourists'
Measles outbreak in Hamilton came from the Philippines
Clopidogrel increases bleeding after robotic CABG
Ontario committee report: Medbuy to blame for diluted chemo drugs error
Ketamine can treat severe depression


Canada Health Accord expires, prompting protest, uncertainty
CBC News
Patients, caregivers and doctors say the ending of Canada's 10-year-old, $41 billion health accord highlights the growing inequity that threatens to fracture medicare. The deal between Ottawa and the provinces and territories provided stable funding and set common goals on wait times, home care and prescription drugs.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Drug reviews mostly stay secret
Toronto Star
Health Canada is keeping secret the vast majority of the drug reviews it conducts despite a clear promise from the federal minister to publish this critical safety information. Only 24 of 152 drug reviews completed last year by Health Canada are being considered for public release, the Toronto Star has learned. The drug safety reviews that will be open to the public are those triggered by alarms raised by foreign regulators, medical or scientific literature or Health Canada's routine monitoring activities.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Think twice about tests, doctors urged
The Leader-Post
The nation's doctors have compiled a list of questionable or worthless tests and procedures, in every specialty of medicine, that offer little benefit, and possible harm, including X-rays for lower back pain or CT scans for uncomplicated headaches. The Choosing Wisely Canada campaign targets tests and interventions that are often a waste of money and don't help patients recover sooner.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE

Sponsored Content


Canadian researchers developing treatment for celiac disease
Global News
You won't be able to order anything off the menu at a restaurant, but new Canadian research could give people living with celiac disease some flexibility in what they eat. McMaster University researchers say they've discovered a molecule that could hold the key to developing a new therapy to help people with celiac disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study finds 1 in 3 prescriptions unfilled, some for chronic conditions
Ottawa Citizen
A new Canadian study suggests nearly one in three new prescriptions goes unfilled, with expensive drugs and medications used to control some chronic conditions more likely not to be taken as directed. The first author of the paper admits that she and her colleagues were startled at the magnitude of the gap between prescriptions written and prescriptions filled.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Complete Unit Dose Packaging

If your hospital is using automated dispensing cabinets or Bar Code Medication Administration at the bedside you should consider Pentapack unit dose packaging for your orals, liquids, suppositories and ampoules. Pentapack is a complete and inexpensive system which offers a variety of packaging and labelling formats. For more information contact Manrex at 1.800.665.7652 or visit www.manrex.com.
 


Government announces new steps to help medical community with marijuana for medical purposes
Government of Canada
Marijuana is not an approved drug or medicine in Canada and has not gone through the necessary rigorous scientific trials for efficacy or safety. Health Canada does not endorse the use of marijuana, but the courts have required reasonable access to a legal source of marijuana for medical purposes. As a result, the Government of Canada believes that this must be done in a controlled fashion to protect public health and safety.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Relationships of services, associations with antibiotic-resistant organisms in Canadian acute care hospitals
AJIC
Environmental contamination in hospitals with antibiotic-resistant organisms (AROs) is associated with patient contraction of AROs. This study examined the working relationship of Infection Prevention and Control (IPAC) and Environmental Services and the impact of that relationship on ARO rates.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Toronto hospital courts wealthy 'medical tourists'
The Globe and Mail
A major Toronto hospital is piloting a new way to raise revenue in an era of tight health care budgets: Selling medical treatment to wealthy foreign patients paying out-of-pocket for Canadian care. Sunnybrook Hospital's board quietly approved an international patient program at the end of last year that has so far welcomed a Barbadian woman who paid about $60,000 for radiation treatment for breast cancer, and a Jamaican man who paid $20,000 for radiotherapy for prostate cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Making Us A Wise Choice

As a manufacturer of generic drugs our flexibility and turnaround times exceed the industry standards.
 


Measles outbreak in Hamilton came from the Philippines
CBC News
The measles case announced by public health officials over the weekend is linked to a previous case in Hamilton from earlier this month, CBC has learned. The most recent case stems from a confirmed measles infection that came from a man who travelled to the Philippines last month, says Hamidah Meghani, associate medical officer of health for the city.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
MOST POPULAR ARTICLE
TRENDING ARTICLE
Canada Health Accord expires, prompting protest, uncertainty
CBC News
Patients, caregivers and doctors say the ending of Canada's 10-year-old, $41 billion health accord highlights the growing inequity that threatens to fracture medicare. The deal between Ottawa and the provinces and territories provided stable funding and set common goals on wait times, home care and prescription drugs.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Highlights of the new 7th edition of the Canadian Tuberculosis Standards
Public Health Agency of Canada
In Canada, tuberculosis remains a significant health concern. The overall reported incidence of active tuberculosis cases continues to decline, but certain sub-populations, such as Aboriginal and foreign-born populations, are disproportionately affected. To date, dedicated research has allowed us to progress in our understanding of the pathogenesis, immunology, and epidemiology of tuberculosis as well as in the development of new diagnostic and therapeutic tools.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Pharmacists can help with opioid constipation
Pharmacy Practice News
About half of physicians who prescribe opioids for long-term use do not take steps to ensure their patients are getting adequate prophylaxis for a common, debilitating side effect of the pain medication — opioid-induced constipation, a new study suggests. Fortunately, pharmacists in at least one health-system are stepping up to the challenge by enacting a prophylactic bowel regimen in the palliative care unit.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


Clopidogrel increases bleeding after robotic CABG
Pharmacy Practice News
Patients should not take the anti-platelet drug clopidogrel for five days before undergoing robotic coronary artery bypass graft (CABG) procedures, according to researchers at the University of Arizona. In 2011, the American Heart Association issued a recommendation to hold clopidogrel for five days before traditional CABG, but the organization had not made a similar statement for the robotic procedure.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Ontario committee report: Medbuy to blame for diluted chemo drugs error
CTV News
National group purchasing organization Medbuy is ultimately responsible for 1,202 cancer patients in Ontario and New Brunswick receiving diluted chemotherapy drugs in 2012, an Ontario legislative committee has concluded. The company didn't do its due diligence in arranging a $2.6 million contract with Marchese Health Care, which provided the diluted drug mixtures, the all-party committee said in a recent report.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Ketamine can treat severe depression
Drug Discovery & Development Magazine
The first U.K. study of the use of ketamine intravenous infusions in people with treatment-resistant depression has been carried out in an NHS clinic by researchers at Oxford Health NHS Foundation Trust and the University of Oxford. The researchers confirmed that ketamine has a rapid anti-depressant effect in some patients with severe depression who have not responded to other treatments.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    OTC cold meds may cause serious side effects (Drug Topics)
Study: Flu vaccine production issue may be behind last year's modest protection (The Vancouver Sun)
Morning-after pills to carry warnings for heavier women (CTV News)
CMA: Be wary of "prescribing" medical marijuana (CMAJ)

Don't be left behind. Click here to see what else you missed.


 


CSHP e-Newsbrief

Frank Humada, Director of Publishing, MultiView 289.695.5422
Download media kit

Siobhan Cole, Senior Content Editor, MultiView 289.695.5423   
Contribute news


To unsubscribe, click here.

Recent issues

April 7, 2014 Blast
April 2, 2014
March 26, 2014
March 19, 2014






50 Minthorn Blvd., Suite 800, Thornhill, ON, L3T 7X8